Atherosclerosis: Cell biology and lipoproteins

Current Opinion in Lipidology

Volumn 26, Issue 2, 2015, Pages 152-153

  Lu, Hong ^a   Daugherty, Alan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SUBTILISIN; LIPOPROTEIN;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CYTOLOGY; GENE MUTATION; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; NOTE; PRIORITY JOURNAL; ANIMAL; BLOOD; COMPLICATION; KNOCKOUT MOUSE; PATHOLOGY;

ANIMALS; ATHEROSCLEROSIS; CELL BIOLOGY; CHOLESTEROL; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; MICE, KNOCKOUT;

EID: 84938059982     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000166     Document Type: Note

References (11)

1. Daugherty A, Rateri DL. Development of experimental designs for atherosclerosis studies in mice. Methods 2005; 36:129-138.
2. Roche-Molina M, Sanz-Rosa D, Cruz FM, et al. Induction of sustained hypercholesterolemia by single adeno-Associated virus-mediated gene transfer of mutant hPCSK9. Arterioscler Thromb Vasc Biol 2015; 35:50-59.
3. Bjorklund MM, Hollensen AK, Hagensen MK, et al. Induction of atherosclerosis in mice and hamsters without germline genetic engineering. Circ Res 2014; 114:1684-1689.
4. Daugherty A, Tabas I, Rader DJ. Accelerating the pace of atherosclerosis research. Arterioscler Thromb Vasc Biol 2015; 35:11-12.
5. Abifadel M, Varret M, Rabes JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003; 34:154-156.
6. Maxwell KN, Breslow JL. Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia. Curr Opin Lipidol 2005; 16:167-172.
7. Rashid S, Curtis DE, Garuti R, et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci USA 2005; 102:5374-5379.
8. Lalanne F, Lambert G, Amar MJ, et al. Wild-Type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells. J Lipid Res 2005; 46:1312-1319.
9. Ishibashi S, Herz J, Maeda N, et al. The two-receptor model of lipoprotein clearance: tests of the hypothesis in knockout mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 1994; 91:4431-4435.
10. Chorba JS, Shokat KM. The proprotein convertase subtilisin/kexin type 9 (PCSK9) active site and cleavage sequence differentially regulate protein secretion from proteolysis. J Biol Chem 2014; 289:29030-29043.
11. Canuel M, Sun X, Asselin MC, et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1). PLoS One 2013; 8:e64145.